Novo Nordisk has partnered with Ascendis Pharma on less frequently dosed drugs for obesity and other metabolic diseases, ...

Incyte filed a lawsuit to try to block the launch of Leqselvi, claiming that the drug infringed a US patent (No. 9,662,335) ...

NHS England has started a pilot trial of an iPhone app and device combination that could be used by nursing staff to speed up ...

Lawyers for AstraZeneca, Bristol-Myers Squibb, and Johnson & Johnson argued at a panel hearing in Philadelphia late last week ...

Generic drugmaker Accord Healthcare has announced a £50 million ($65 million) investment in the UK that will include the ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated ...

The fine of €462.6 million ($503 million) is believed to be the largest imposed on a pharma company for breaking antitrust ...

Novartis has exclusive rights to MRT-6160 and follow-up VAV1 degraders and will be responsible for development activities ...

As the race to deliver personalised engagement at scale heats up, artificial intelligence (AI) has become the critical ...

Islet cell transplantation is used in type 1 diabetes to replace the insulin-producing beta cells that are destroyed by the ...

Abortion is a major issue this election cycle, and pharma was pulled into it last year when abortion detractors successfully ...

The NHS often relies on professional interpreters and translation services to bridge these gaps, but this comes at a ...